Reliability and validity of the Advanced Basal Cell Carcinoma Index (aBCCdex)

British Journal of Dermatology

Volumn 173, Issue 3, 2015, Pages 713-719

  Mathias, S D ^a   Chren, M M ^b   Crosby, R D ^c   Colwell, H H ^a   Yim, Y M ^d   Reyes, C ^d   Chen, D M ^d   Fosko, S W ^e  

^a Health Outcomes Solutions   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UND School of Medicine & Health Sciences Southeast Campus   (United States)

^d GENENTECH INC   (United States)

^e SAINT LOUIS UNIVERSITY CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED BASAL CELL CARCINOMA INDEX; ADVANCED CANCER; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER PATIENT; CLINICAL EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; SHORT FORM 12; SKIN DISEASE ASSESSMENT; UNITED STATES; ADOLESCENT; BASAL CELL NEVUS SYNDROME; COST OF ILLNESS; EVALUATION STUDY; MIDDLE AGED; PSYCHOLOGY; QUALITY OF LIFE; SKIN TUMOR; STANDARDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; COST OF ILLNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; PSYCHOMETRICS; QUALITY OF LIFE; SKIN NEOPLASMS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84942311642     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13877     Document Type: Article

References (23)

1. Skin Cancer Foundation. Basal cell carcinoma. Available at: http://www.skincancer.org/skin-cancer-information/basal-cell-carcinoma (last accessed 3 June 2015).
2. Genetics Home Reference. Gorlin syndrome. Available at: http://ghr.nlm.nih.gov/condition/gorlin-syndrome (last accessed 3 June 2015).
3. Tang JY, Mackay-Wiggan JM, Aszterbaum M, et al., Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med 2012; 366: 2180-8.
4. So PL, Tang JY, Epstein EH,. Novel investigational drugs for basal cell carcinoma. Expert Opin Investig Drugs 2010; 19: 1099-112.
5. Chren MM, Sahay AP, Bertenthal DS, et al., Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol 2007; 127: 1351-7.
6. Ghajarzadeh M, Ghiasi M, Kheirkhah S,. Associations between skin diseases and quality of life: a comparison of psoriasis, vitiligo, and alopecia areata. Acta Med Iran 2012; 50: 511-15.
7. Shah M, Mavers M, Bree A, et al., Quality of life and depression assessment in nevoid basal cell carcinoma syndrome. Int J Dermatol 2011; 50: 268-76.
8. Tidman MJ,. Prompt treatment of acne improves quality of life. Practitioner 2012; 256: 15-17.
9. Bates AS, Davis CR, Takwale A, Knepil GJ,. Patient-reported outcome measures in nonmelanoma skin cancer of the face: a systematic review. Br J Dermatol 2013; 168: 1187-94.
10. Burdon-Jones D, Gibbons K,. The Skin Cancer Quality of Life Impact Tool (SCQOLIT): a validated health-related quality of life questionnaire for non-metastatic skin cancers. J Eur Acad Dermatol Venereol 2013; 27: 1109-13.
11. Chren MM, Lasek RJ, Sahay AP, Sands LP,. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg 2001; 5: 105-10.
12. Dreyfus I, Taïeb C, Barbarot S, et al., IQoL-32: a new ichthyosis-specific measure of quality of life. J Am Acad Dermatol 2013; 69: 82-7.
13. Matthews BA, Rhee JS, Neuburg M, et al., Development of the Facial Skin Care Index: a health-related outcomes index for skin cancer patients. Dermatol Surg 2006; 32: 924-34; discussion 934.
14. Mathias SD, Chren MM, Colwell HH, et al., Assessing health-related quality of life for advanced basal cell carcinoma and basal cell carcinoma nevus syndrome: development of the first disease-specific patient-reported outcome questionnaires. JAMA Dermatol 2014; 150: 169-76.
15. BCCNS Life Support Network. About BCCNS Life Support Network. Available at: http://www.gorlinsyndrome.org/about-bccns.aspx (last accessed 3 June 2015).
16. Ware J Jr, Kosinski M, Keller SD,. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-33.
17. Cronbach L,. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-333.
18. Lohr KN, Aaronson NK, Alonso J, et al., Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin Ther 1996; 18: 979-92.
19. Nunnally JC, Bernstein IH,. Psychometric Theory, 3rd edn. New York: McGraw-Hill, 1994.
20. Cohen J,. Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Hillsdale, New Jersey: Lawrence Erlbaum, 1988.
21. Stucki G, Liang MH, Fossel AH, Katz JN,. Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis. J Clin Epidemiol 1995; 48: 1369-78.
22. Guyatt GH, Bombardier C, Tugwell PX,. Measuring disease-specific quality of life in clinical trials. Can Med Assoc J 1986; 134: 889-95.
23. Chen T, Bertenthal D, Sahay A, et al., Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. Arch Dermatol 2007; 143: 1386-92.